The Macula Society is pleased to announce that the Promotional Support Packet for the upcoming 49th Annual Meeting, taking place February 25–28, 2026 at the iconic Hotel del Coronado in Coronado, California, is now available for corporate partners and prospective...
The Macula Society is excited to announce the launch of its newly redesigned website, offering a modernized, mobile-friendly experience for members and visitors alike. Built on the WordPress platform, the new site allows for more frequent updates to news,...
Retina disease research has entered a promising era, driven by advances in genetics, imaging technologies, and regenerative medicine. Conditions like age-related macular degeneration (AMD), diabetic retinopathy, and inherited retinal dystrophies are among the leading...
Researchers at LMU Munich are looking for ophthalmology professionals from North America for an online qualitative study on artificial intelligence (AI) in ophthalmology. To understand ophthalmology professionals’ perceptions of AI and to identify relevant factors for...
We are administering a survey study about white dot syndromes (WDS) to understand the insights of uveitis and retina specialists about these complex and varied entities. We invite you to participate in this study by completing an online survey. It will take less than...
Join us for the 6th Biennial Symposium on AMD, taking place on September 29-30, 2023, at the Starr Center at the Schepens Eye Research Institute of Mass Eye and Ear in Boston. The conference aims to highlight the latest innovations in AMD disease research. This event...
Join us for the 6th Biennial Symposium on AMD, taking place on September 29-30, 2023, at the Starr Center at the Schepens Eye Research Institute of Mass Eye and Ear in Boston. The conference aims to highlight the latest innovations in AMD disease research. This event...
The DRCR Retina Network is planning an exciting new Phase III clinical trial to prevent visual acuity loss due to radiation retinopathy (RR). Eligible participants will be randomized to receive either repeated injections of anti-VEGF, long-active steroid, or...
Lloyd P. Aiello, MD, PhD